THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY
🇨🇳China
Bioequivalence Study of Empagliflozin And Linagliptin Tablets in Healthy Chinese Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 106
- Registration Number
- NCT05956522
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China
Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial
Not Applicable
Recruiting
- Conditions
- Gastric Cancer
- Interventions
- Drug: Chimeric antigen receptor T cell preparation targeting Claudin18.2
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 9
- Registration Number
- NCT05952375
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Not Applicable
Recruiting
- Conditions
- Gastric CancerNeoadjuvant Chemotherapy
- Interventions
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 318
- Registration Number
- NCT05901779
- Locations
- 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China
XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation
Not Applicable
Recruiting
- Conditions
- Colon Cancer
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 9
- Registration Number
- NCT05875402
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
Phase 3
Recruiting
- Conditions
- Gastric Cancer
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 616
- Registration Number
- NCT05871099
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Bioequivalence Study of Apixaban Tablets in Healthy Chinese Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 54
- Registration Number
- NCT05841446
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China
Bioequivalence Study of Two Irbesartan in Healthy Chinese Subjects
Phase 1
Completed
- Conditions
- Therapeutic Equivalency
- Interventions
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 68
- Registration Number
- NCT05786339
- Locations
- 🇨🇳
Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
Not Applicable
Recruiting
- Conditions
- Renal CystRenal Cell CarcinomaUreteral TumorBladder CancerProstate CancerRenal CalculiPenile CancerUreteropelvic Junction ObstructionAdrenal TumorRenal Pelvis Carcinoma
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 100
- Registration Number
- NCT05739812
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects
Phase 1
Completed
- Conditions
- Hyperlipidemias
- Interventions
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 59
- Registration Number
- NCT05681247
- Locations
- 🇨🇳
Clinical Research Center, Qingdao, Shandong, China
Coca-cola's Clinical Effects on Gastric Phytobezoars
Not Applicable
Completed
- Conditions
- Bezoars
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 492
- Registration Number
- NCT05645263
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China